Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  omacetaxine mepesuccinate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 39 for your search:
Start Over
Phase I/II Chemotherapy with Homoharringtonine for Refractory Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-82154, NCI-W83-0248, W83-0248
Phase II Study of Homoharringtonine with Low Dose Cytarabine In Patients with Chronic Myelogenous Leukemia (Summary Last Modified 11/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93144, NCI-T93-0192D, T93-0192
Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02233, MDA-DM-93151, NCI-T93-0191D, CDR0000063647, T93-0191, NCT00002574
Phase II Study of Low-Dose Cytarabine/Homoharringtonine for Chronic Myelogenous Leukemia in Chronic Phase (Summary Last Modified 11/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: DFCI-95005, NCI-T94-0199D, T94-0199
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: DM97-229, U01CA070172, P30CA016672, MDA-DM-97229, MDA-FDR001791, NCI-T97-0105, CDR0000066114, T97-0105, NCT00003239
Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02786, CALGB-19804, U10CA031946, CLB-19804, NCT00003694
Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02360, ID 99-032, N01CM17003, CDR0000068237, MDA-ID-99032, MDA-FDR001783, NCI-T99-0044, T99-0044, NCT00006364
Phase II Chemotherapy with Homoharringtonine for Metastatic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DM-8209, NCI-C83-0508
Phase II Chemotherapy with 5-Day Intermittent Intravenous Homoharringtonine for Refractory Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8241, NCI-T83-0903C, T83-0903
Phase II Chemotherapy with Homoharringtonine in Adult Patients with Stage IV Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DM-8253, NCI-C83-0557
Phase II Chemotherapy with Homoharringtonine in Adults with Advanced, Refractory Bony and Soft Tissue Sarcomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: MDA-DM-8254, NCI-C83-0556
Phase II Chemotherapy with Homoharringtonine for Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DM-8281, NCI-C83-0723
Phase II Chemotherapy with Homoharringtonine for Recurrent or Metastatic, Refractory Epithelial Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8235, NCI-T83-0875D, T83-0875
Phase II Pilot Chemotherapy with Homoharringtonine on an 8-Day Continuous Infusion Schedule for Refractory Adult ANLL
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: EST-PA-484, EST-P-A484
Phase II Pilot Chemotherapy with VP-16/HH in Adults with Refractory ANLL
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MSKCC-83144, NCI-T84-0273C, T84-0273
Phase II Chemotherapy with Homoharringtonine for Previously Treated ANLL, AUL, or Blastic Phase of CML
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: AECM-8422, NCI-T83-1157D, T83-1157
Phase II Chemotherapy with Homoharringtonine in Patients with Refractory Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8407, NCI-T84-0390D, T84-0390
Phase II Master Protocol to Evaluate New Chemotherapeutic Agents in Advanced Squamous Cell Carcinoma of the Head and Neck --- Homoharringtonine
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-85N1, NCI-T85-0185D, T85-0185
Phase II Pilot Study of Chemotherapy with HHT and AMSA in Patients with Refractory Acute Nonlymphoblastic Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8585, NCI-T85-0260C, T85-0260
Phase II Chemotherapy with Homoharringtonine in Patients with Progressive or Recurrent High Grade Malignant Astrocytomas or High Grade Spinal Cord Tumors (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: PCCC-8555, NCI-T86-0024D, T86-0024
Phase II Chemotherapy with Homoharringtonine in Children with Refractory Nonlymphoblastic Leukemia (Summary Last Modified 06/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-8761
Phase II Chemotherapy with Homoharringtonine in Patients with non-Hodgkin's Lymphoma (Summary Last Modified 03/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: UNM-0587C, NCI-T87-0099O, T87-0099
Phase II Chemotherapy with Homoharringtonine in Patients with Myelodysplastic Syndromes (Summary Last Modified 10/87)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: NYMC-T87-0097, NCI-T87-0097O, T87-0097
Phase II Chemotherapy with Homoharringtonine in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: EST-PC-584, EST-P-C584
Phase II Study of Continuous Infusion Homoharringtonine in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (Summary Last Modified 11/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-88132, NCI-T88-0243C, T88-0243
Start Over